MUMBAI — Sun Pharmaceutical Industries on Wednesday said Ranbaxy will be delisted from the domestic stock exchanges following the completion of the US $4 billion merger of the two drug firms. "Followi...
SUBSCRIBE AND FOLLOW
Get top stories and blog posts emailed to me each day. Newsletters may offer personalized content or advertisements.